Gujarat Kidney's IPO surged 6% on debut, raising ₹251 crore with strong retail demand.

Gujarat Kidney and Super Speciality Ltd. made a strong market debut on December 30, 2025, with shares rising nearly 6% above the IPO price of ₹114, opening at ₹120.75 on BSE and ₹120 on NSE. The ₹251 crore IPO, fully a fresh issue, saw 5.21 times subscription, driven by robust retail demand. Proceeds will fund hospital acquisitions, new facility construction, equipment purchases, and debt repayment. The company operates seven multi-specialty hospitals in Gujarat with 490 beds, focusing on renal and super-specialty care.